Pembrolizumab After RCC Surgery: Potential New Standard of Care
Pembrolizumab following surgery for clear cell renal cell carcinoma (RCC) may offer a potential new standard of care, according to
Read MorePembrolizumab following surgery for clear cell renal cell carcinoma (RCC) may offer a potential new standard of care, according to
Read MoreA team of researchers at the École Polytechnique fédérale de Lausanne (EPFL; Lausanne, Switzerland) have developed a continuous drug monitoring
Read MoreAdministration of neoadjuvant nivolumab plus chemotherapy did not affect the feasibility or timing of surgery or the extent of surgical
Read MoreThe annual greenhouse gas emissions of a planned neutrino experiment could be on a par to the production of 1000
Read MoreConsuming large amounts of daily caffeine may increase the risk of glaucoma more than three-fold for those with a genetic
Read MoreAvellino Launches AvaGen as First Genetic Test to Quantify Keratoconus Risk and Presence of Corneal Dystrophies. Novel Test Provides Early
Read MoreIt’s one thing to crave a big meal or a bottomless bag of your favorite snack. It’s another to be
Read MoreAvenda Health, a medtech company based in Santa Monica, California has developed the Focal Therapy System. It provides AI-powered prostate
Read MoreRubedo Life Sciences announced that it has partnered with Cedars-Sinai Medical Center, also in California, to advance its idiopathic pulmonary fibrosis
Read MoreEurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for rare diseases
Read More